GL1X · GenesisL1 explorer

MolNFT v1 · #25798 · protein

HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor

1W5X · Pol polyprotein: “HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor”. X-ray diffraction, 1 ligand (BE5), 1 pocket (best druggability 0.71). MolNFT v1 #25798 on GenesisL1: 3D structure, binding…

PDB
1W5X
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pol polyprotein
EC
3.4.23.16
UniProt
P03366
Ligands
BE5
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPol polyprotein (EC 3.4.23.16)protein997% helix, 54% strandP03366

Ligands and binding sites

  • BE5 · (2R,3R,4R,5R)-2,5-bis[(2,3-difluorobenzyl)oxy]-3,4-dihydroxy-N,N'-bis[(1s,2r)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexan ediamide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13140.710.8438BE5

Interfaces

1 interface between chains.

  • A–B · 1845 Ų buried · 41 hydrogen bonds · protein-protein

Compared structures

  • 1W5X · HIV-1 protease in complex with fluoro substituted diol-based C2- symmetric inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.